tiprankstipranks
Apollomics presents vebreltinib data at AACR meeting
PremiumThe FlyApollomics presents vebreltinib data at AACR meeting
3M ago
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PremiumPress Releases
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
3M ago
Apollomics price target lowered to $5 from $17 at H.C. Wainwright
PremiumThe Fly
Apollomics price target lowered to $5 from $17 at H.C. Wainwright
4M ago
Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress ReleasesApollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
6M ago
Apollomics receives Nasdaq notification regarding minimum bid price
PremiumThe Fly
Apollomics receives Nasdaq notification regarding minimum bid price
6M ago
Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
PremiumPress Releases
Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
6M ago
Apollomics presents interim data from ongoing Phase 2 trials with vebreltinib
PremiumThe FlyApollomics presents interim data from ongoing Phase 2 trials with vebreltinib
8M ago
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
PremiumPress Releases
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
8M ago
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
PremiumPress Releases
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100